Psyllium Postprandial Glucose Randomized Trial Evidence Table

Structured evidence table for Psyllium Postprandial Glucose Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Psyllium Postprandial Glucose Randomized TrialIt identified practical strategies based on their potential interactions for combination therapy to mitigate gastrointestinal adverse effects, improved durability after drug withdrawal, and proposed testable hypotheses for precision fiber selection during and after GLP-1RA therapy.4Wang Yuxin (2026)Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
Psyllium Postprandial Glucose Randomized TrialConventional management has largely relied on lifestyle modification, particularly caloric restriction and increased physical activity.4Wang Yuxin (2026)Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
Psyllium Postprandial Glucose Randomized TrialAt present, such bidirectional interactions should be regarded as conceptual, hypothesis-generating frameworks rather than evidence-based treatment strategies.4Wang Yuxin (2026)Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
Psyllium Postprandial Glucose Randomized TrialThis review uniquely synthesized mechanisms linking GLP-1 receptor agonists and dietary fibers through the gut–brain axis, microbiota-derived metabolites, and immune modulation.4Wang Yuxin (2026)Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
Psyllium Postprandial Glucose Randomized TrialType 2 diabetes (T2D) represents a major public health challenge, being associated with significant metabolic and cardiovascular complications.4Hajnal F (2026)The Role of Dietary Fibers in the Management of Type 2 Diabetes: A Synthesis of Current Evidence and Clinical Implications.
Psyllium Postprandial Glucose Randomized TrialEvidence-based nutritional interventions are essential for the prevention and management of the disease.4Hajnal F (2026)The Role of Dietary Fibers in the Management of Type 2 Diabetes: A Synthesis of Current Evidence and Clinical Implications.
topicPsyllium Postprandial Glucose Randomized Trial
claimIt identified practical strategies based on their potential interactions for combination therapy to mitigate gastrointestinal adverse effects, improved durability after drug withdrawal, and proposed testable hypotheses for precision fiber selection during and after GLP-1RA therapy.
evidence level4
citationWang Yuxin (2026)
sourceDietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
topicPsyllium Postprandial Glucose Randomized Trial
claimConventional management has largely relied on lifestyle modification, particularly caloric restriction and increased physical activity.
evidence level4
citationWang Yuxin (2026)
sourceDietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
topicPsyllium Postprandial Glucose Randomized Trial
claimAt present, such bidirectional interactions should be regarded as conceptual, hypothesis-generating frameworks rather than evidence-based treatment strategies.
evidence level4
citationWang Yuxin (2026)
sourceDietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
topicPsyllium Postprandial Glucose Randomized Trial
claimThis review uniquely synthesized mechanisms linking GLP-1 receptor agonists and dietary fibers through the gut–brain axis, microbiota-derived metabolites, and immune modulation.
evidence level4
citationWang Yuxin (2026)
sourceDietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
topicPsyllium Postprandial Glucose Randomized Trial
claimType 2 diabetes (T2D) represents a major public health challenge, being associated with significant metabolic and cardiovascular complications.
evidence level4
citationHajnal F (2026)
sourceThe Role of Dietary Fibers in the Management of Type 2 Diabetes: A Synthesis of Current Evidence and Clinical Implications.
topicPsyllium Postprandial Glucose Randomized Trial
claimEvidence-based nutritional interventions are essential for the prevention and management of the disease.
evidence level4
citationHajnal F (2026)
sourceThe Role of Dietary Fibers in the Management of Type 2 Diabetes: A Synthesis of Current Evidence and Clinical Implications.

Source documents

  1. Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
  2. The Role of Dietary Fibers in the Management of Type 2 Diabetes: A Synthesis of Current Evidence and Clinical Implications.